Abstract
OBJECTIVE To investigate the expression of the RECK gene in human breast (cancer) cell lines, and to determine the relationship between RECK gene expression and the invasive capacity of the breast cancer cell lines.
METHODS The invasive capacity of breast (cancer) cell lines including HBL-100, MCF-7 and MDA-MB-435S were determined by the Transwell method. The protein expression levels of RECK, MMP-2 and MMP-9 genes in these three cell lines were measured by immunocytochemical methods. The expressions of the RECK gene and protein level were measured by RT-PCR and Western blots in the cell lines respectively.
RESULTS The order of the invasive capacity of the breast (cancer) cell lines was MDA-MB-435S, being the highest, and HBL-100, being the lowest. The invasive capacity difference between any two groups among the three groups was significant (P<0.01). The protein expression level of the RECK gene in the HBL-100 cell line was highest, and no expression was detected in MDA-MB-435S cells. Moreover, the expression of the RECK gene was negatively correlated with the expression of the MMP-2 and MMP-9 genes. The mRNA level of the RECK gene in HBL-100 cells was the highest, but no expression was found in the MDA-MB-435S cells (P<0.001).
CONCLUSION There was a significant negative correlation between the expression level of the RECK gene and invasive capacity in vitro, and the RECK gene expression showed an inverse proportion to that of the MMP-2, MMP-9 genes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets. Int J Cancer. 2002,99:157–166.
Benaud C, Dickson RB, Thompson EW. Roles of the matrix metalloproteinases in mammary gland development and cancer. Breast Cancer Res Treat. 1998;50:97–116.
Duffy MJ, Maguire TM, Hill A, et al. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2000;2:252–257.
Toshihiko M, Ryuichiro D, Takatomo K, et al. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clinical Cancer Res. 2003;9:1779–1784.
Eisenberg H, Hochner M, Sadeh Z, et al. Establishment of the genomic structure and identification of thirteen single-nucleotide polymorphisms in the human RECK gene. Gene Mapping, Cloning and Sequencing. 2002;97:58–61.
Takahashi C, Sheng Z, Horan TP et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA. 1998;95:13221–13226.
Oh J, Takahashi R, Kondo S et al. The membrane-ahchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell. 2001;107:789–800.
Furumoto K, Arii S, Mori A et al. RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinopathological factors and its clinical significance. Hepatology 2001;33:189–195.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sun, T., Jiang, D., Li, J. et al. High expression of the RECK gene in breast cancer cells is related to low invasive capacity. Chin. J. Clin. Oncol. 3, 322–325 (2006). https://doi.org/10.1007/s11805-006-0096-y
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11805-006-0096-y